FASTK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.114200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.899600E-01
Normal-vs-Stage2
8.443200E-01
Normal-vs-Stage3
4.731600E-01
Normal-vs-Stage4
3.231800E-01
Stage1-vs-Stage2
5.285000E-01
Stage1-vs-Stage3
2.722000E-01
Stage1-vs-Stage4
2.473800E-01
Stage2-vs-Stage3
2.021600E-01
Stage2-vs-Stage4
2.064400E-01
Stage3-vs-Stage4
9.864400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.242600E-01
Normal-vs-AfricanAmerican
8.559800E-01
Normal-vs-Asian
2.599800E-01
Caucasian-vs-AfricanAmerican
9.502400E-01
Caucasian-vs-Asian
1.925810E-01
AfricanAmerican-vs-Asian
4.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.200000E-01
Normal-vs-Female
8.058600E-01
Male-vs-Female
8.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.295800E-01
Normal-vs-Age(41-60Yrs)
8.102800E-01
Normal-vs-Age(61-80Yrs)
8.679200E-01
Normal-vs-Age(81-100Yrs)
5.607000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.050400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.925200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.467800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.318000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.977000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.268800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.846200E-01
Normal-vs-Daily Drinker
3.720800E-01
Normal-vs-Weekly Drinker
3.227800E-01
Normal-vs-Occasional Drinker
8.204600E-01
Normal-vs-Social Drinker
5.586200E-01
Non Drinker-vs-Daily Drinker
2.458000E-02
Non Drinker-vs-Weekly Drinker
2.282100E-02
Non Drinker-vs-Occasional Drinker
5.748600E-01
Non Drinker-vs-Social Drinker
2.106200E-01
Daily Drinker-vs-Weekly Drinker
8.574200E-01
Daily Drinker-vs-Occasional Drinker
1.732170E-01
Daily Drinker-vs-Social Drinker
6.872800E-01
Weekly Drinker-vs-Occasional Drinker
1.554550E-01
Weekly Drinker-vs-Social Drinker
6.057800E-01
Occasional Drinker-vs-Social Drinker
4.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.532400E-01
Normal-vs-Grade 2
8.101000E-01
Normal-vs-Grade 3
8.233400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.616600E-01
Grade 1-vs-Grade 3
6.383600E-01
Grade 1-vs-Grade 4
8.532400E-01
Grade 2-vs-Grade 3
6.941200E-01
Grade 2-vs-Grade 4
8.101000E-01
Grade 3-vs-Grade 4
8.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.693000E-01
Normal-vs-NonDiabetic
6.073600E-01
Diabetic-vs-NonDiabetic
1.221160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.148810E-01
Normal-vs-NoPancreatitis
7.909600E-01
Pancreatitis-vs-NoPancreatitis
1.841780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.384800E-01
Normal-vs-N1
9.236600E-01
N0-vs-N1
2.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.153200E-01
Normal-vs-TP53-NonMutant
8.780400E-01
TP53-Mutant-vs-TP53-NonMutant
6.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
